Could skipping Late-Night snacks slow Alzheimer's? new trial investigates
NCT ID NCT06548191
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether restricting eating to a 10-hour daytime window (fasting 14 hours overnight) can reduce sleep problems and cognitive decline in people with mild cognitive impairment or early-to-moderate Alzheimer's disease. Sixty older adults will try the diet for 3 or 6 months, keeping a diary and wearing an activity tracker. The main goal is to see if this approach is feasible and acceptable for this group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
time-restricted eating (14-hour nightly fasting)
What this could lead to
If it works, this could point toward a simple lifestyle change to help manage symptoms and slow cognitive decline in Alzheimer's disease.
What could go wrong
This is a small early-phase trial testing feasibility, not effectiveness. The intervention may be hard for older adults to follow, and any benefits may be modest or not confirmed in larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shiley Marcos Alzheimer's Disease Center
RECRUITINGSan Diego, California, 92093, United States
Contact
Contact Email: •••••@•••••
Contact